Dare Bioscience Inc.
Chart
Good to know: Investing in stocks tends to provide long-term positive returns, but it also involves risks. You can lose some or all of your investment. Past performance of this stock is not a reliable indicator of future results. Data from external providers has not been altered by Saxo. See full data disclaimer
About Dare Bioscience Inc.
Dare Bioscience Inc is a biopharmaceutical company committed to advancing products for women's health. The company identifies, develops, and brings to market a diverse portfolio of differentiated therapies that prioritize women's health and well-being, expand treatment options, and improve outcomes, in the areas of contraception, fertility, and vaginal and sexual health. The company's first product, XACIATO is a single-dose vaginal gel prescription product for the treatment of bacterial vaginosis in females 12 years of age and older. The company's portfolio includes two product candidates in clinical development namely, Ovaprene and Sildenafil Cream. It has one operating segment, women’s health.
/ 
Frequently asked questions
To buy Dare Bioscience Inc. stock, open a Saxo account and fund it. With SaxoInvestor or SaxoTrader, you can easily search for Dare Bioscience Inc. by name or ticker, choose the number of shares, and place your order.
The ticker symbol for Dare Bioscience Inc. is DARE:xnas. You can use this code to quickly find the stock in Saxo’s platforms and track its price and performance.
Dare Bioscience Inc. has its primary listing on NASDAQ. You can trade Dare Bioscience Inc. with a Saxo account, alongside thousands of other stocks worldwide.
Yes, Dare Bioscience Inc. is available to trade on SaxoInvestor and SaxoTraderGO. You can buy shares directly and include Dare Bioscience Inc. as part of a broader investment portfolio. Explore our SaxoInvestor platform.
Learn more about investing and trading at Saxo’s educational content hub. Explore portfolio strategies, types of stocks, diversification, and valuation measures— so you can make more informed decisions when considering shares like Dare Bioscience Inc..